The smart health/medical care polices in recent years focus on building information infrastructure and networks for medical services, including cloud platforms such as Health Cloud and Health Cloud 2.0 to facilitate medical data sharing, improving information networks in rural areas to facilitate the provisioning of smart health/medical care services, or the value-added applications of health/medical care big data. This report provides an overview of Taiwanese government's smart health/medical care policies for the period 2014-2020 with detailed description; provides key players of the supply chain and their nascent developments from system, service, and equipment & device perspectives; examines the industry's shortage and demand from both domestic and overseas markets.
Table of Contents
Taiwanese government’s smart health initiatives
Taiwanese smart health industry supply chain
Taiwanese smart manufacturing industry shortage and demand
List of topics:
Overview of Taiwan's government initiatives for smart health/medical care for the period 2014-2020
Smart health/medical care supply chain and major players of key components, devices & equipment, systems, and services
Major players of Taiwan's smart health/medical care industry supply chain, consisting of planning consultant, system integrator, system vendors, and hardware device and equipment.
Shortage and demand of smart health/medical care observed from the perspectives of applications to ecosystem building.
Shortage assessment of Taiwan's smart health/medical care industry to identify the possible future demand
The minimally invasive surgical systems are comprising of two broad segments surgical robotics and conventional minimally invasive surgical systems which include laparoscopy and endoscopy.Market Analysis and Insights Global and United States Minimally Invasive Surgical Systems MarketThis report focuses on global and United States Minimally Invasive Surgical Systems market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Minimally Invasive Surgical Systems market size is estimated to be worth US 40280 million in 2022 and is forecast to a readjusted size of US 60950 million by 2028 with a CAGR of 7.2 during the review period.
Low dosage hydrate inhibitors are chemicals that help manage flow without the huge volume of chemicals that are required for thermodynamic inhibition.Market Analysis and Insights Global and United States Low dosage Hydrate Inhibitors MarketThis report focuses on global and United States Low dosage Hydrate Inhibitors market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Low dosage Hydrate Inhibitors market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.